EUVIMEDEUVIMED entdecken
Crossref

Chirality-Driven Immune Checkpoint Modulation by Chiral Iridium(III) Nanoparticles

Lu Zhu, Ze Wen, Maokai Yu, Jingyi Zhang, Yue Qin, Shiqi Gao, Yunlong Mao, Yunfei Deng, Tian Tian iD, Shengjin Liu, Wenfeng Jiang iD, Jiajia Ma iD und 5 weitere

Journal of the American Chemical Society · 06.05.2026 · 148 (17) · 17794-17810

DOI: 10.1021/jacs.6c00020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 22.04.2026. Verfasst von Lu Zhu und 16 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Nanjing University, Nanjing 210023, China. Hauptthemen laut MEDLINE: Iridium, Immune Checkpoint Inhibitors, Metal Nanoparticles, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, the Yachen Foundation of Nanjing University, the Jiangsu Provincial Science and Technolgy Plan Special Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IridiumImmune Checkpoint InhibitorsMetal NanoparticlesAntineoplastic AgentsStereoisomerismHumansAnimalsB7-H1 AntigenMice

Substanzen

IridiumImmune Checkpoint InhibitorsB7-H1 AntigenAntineoplastic Agents

Autor:innen und Institutionen

  • School of Life Sciences, Nanjing University, Nanjing 210023, China.
  • Chemistry and Biomedicine Innovation Center (ChemBIC), State Key Laboratory of Coordination Chemistry, School of Chemistry, Nanjing University, Nanjing 210023, China.
  • Zhejiang Fulai New Materials Co., Ltd., Jiaxing 315201, China.
  • State Key Laboratory of Novel Software Technology, Nanjing University, Nanjing 210023, China.
  • Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing 211166, China.
  • College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.

ORCID-Profile: Tian Tian, Wenfeng Jiang, Jiajia Ma, Xiaoyong Wang, Zijian Guo, Wei Wei, Jing Zhao

Förderung

  • Fundamental Research Funds for the Central Universities
  • the Yachen Foundation of Nanjing University
  • the Jiangsu Provincial Science and Technolgy Plan Special Fund

Zitieren

APA

Zhu, L., Wen, Z., Yu, M., Zhang, J., Qin, Y., Gao, S., Mao, Y., Deng, Y., Tian, T., Liu, S., Jiang, W., Ma, J., Wang, X., Guo, Z., Wei, W., Zhao, J., & Wang, X. (2026). Chirality-Driven Immune Checkpoint Modulation by Chiral Iridium(III) Nanoparticles. Journal of the American Chemical Society, 148(17), 17794-17810. https://doi.org/10.1021/jacs.6c00020

Vancouver

Zhu L, Wen Z, Yu M, Zhang J, Qin Y, Gao S, et al. Chirality-Driven Immune Checkpoint Modulation by Chiral Iridium(III) Nanoparticles. Journal of the American Chemical Society. 2026;148(17):17794-17810. doi:10.1021/jacs.6c00020

BibTeX
@article{Zhu2026,
  author = {Zhu, Lu and Wen, Ze and Yu, Maokai and Zhang, Jingyi and Qin, Yue and Gao, Shiqi and Mao, Yunlong and Deng, Yunfei and Tian, Tian and Liu, Shengjin and Jiang, Wenfeng and Ma, Jiajia and Wang, Xiaoyong and Guo, Zijian and Wei, Wei and Zhao, Jing and Wang, Xiuxiu},
  title = {Chirality-Driven Immune Checkpoint Modulation by Chiral Iridium(III) Nanoparticles},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  volume = {148},
  number = {17},
  pages = {17794--17810},
  doi = {10.1021/jacs.6c00020}
}
Kostenlos starten →